Company: FTII
Filing Date: 2025-08-18
Form Type: 8-K
Source: 0001641172-25-024504
Chunk: 4

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-08-18
Form: 8-K
Item: Item 9.01
Chunk 4
---
 Company’s and the Longevity’s management and are not predictions of actual
performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must
not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual
events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances
are beyond the control of the Company and Longevity. These forward-looking statements are subject to a number of risks and uncertainties,
including: changes in domestic and foreign business, market, financial, political and legal conditions; the inability of the parties
to successfully or timely consummate the Business Combination, including the risk that any required stockholder or regulatory approvals
are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected
benefits of the Business Combination; failure to realize the anticipated benefits of the Business Combination; risks relating to the
uncertainty of the projected financial information with respect to the Company and Longevity; risks and costs relating to the regulatory
approvals and compliance applicable to Longevity’s products; the Company’s or Longevity’s ability to obtain sufficient
working capital; the Company’s and Longevity’s level of indebtedness; Longevity’s ability to successfully and timely
acquire, develop, sell and expand its technology and products, and otherwise implement its growth strategy; risks relating to the Company’s
and Longevity’s operations and business, including information technology and cybersecurity risks; risks related to the loss of
requisite licenses; risks relating to potential disruption of current plans, operations and infrastructure of Longevity as a result of
the announcement and consummation of the Business Combination; risks that Longevity is unable to secure or protect its intellectual property;
risks that the combined company experiences difficulties managing its growth and expanding operations; the ability to compete with existing
or new companies that could slow the development of Longevity’s products or cause downward pressure on prices, fewer customer orders,
reduced margins, the inability to take advantage of new business opportunities, and the loss of market share; the amount of redemption
requests made by the Company’s shareholders; the impact of the COVID-19 pandemic; the ability to successfully select, execute or
integrate future acquisitions into the business, which could result in material adverse effects to operations and financial conditions;
and those factors discussed in the sections entitled “ Risk Facstors” and “ Special Note